+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Tissue Imaging Market: Focus on Technology, Product, Application, End User, 14 Countries' Data and Competitive Landscape - Analysis and Forecast, 2020-2030

  • ID: 5026155
  • Report
  • May 2020
  • Region: Global
  • 495 Pages
  • BIS Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio SB
  • Danaher Corporation
  • Fluidigm Corporation
  • Merck KGaA
  • Olympus Corporation

Market Report Coverage - Tissue Imaging

Market Segmentation


  • Application - Disease Research (Cardiology, Neurology, Oncology, Immunology, Infectious Diseases, Others)
  • Diagnosis Research - (Cardiology, Neurology, Oncology, Immunology, Infectious Diseases, Others)
  • Product - Platforms, Microscopes, Accessories, Consumables, Software
  • Technology - Digital Pathology, Flow Cytometry, Immunohistochemistry (IHC), Immunofluorescence, In Situ Hybridization (ISH), Mass Spectrometry Imaging
  • Product - Platforms, Microscopes, Accessories, Consumables, Software
  • End Users – Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Academic & Research Institutions, Hospitals, Diagnostic Laboratories

Regional Segmentation


  • North America - U.S. and Canada
  • Europe - Germany, U.K, Italy, Spain, France, Netherlands, Switzerland, and Rest-of-Europe
  • Asia-Pacific - Japan, China, South Korea, Australia, India, and Rest-of-Asia-Pacific
  • Rest-of-the-World

Growth Drivers


  • Rising Incidence of Disorders Inciting the Use of Tissue Imaging
  • Integration of Digital Technology with Imaging Technologies
  • Shifting Focus Toward Value-Oriented Healthcare Model

Market Challenges


  • Decline in Funds for Research & Development
  • Stringent Regulatory Requirements

Market Opportunities


  • Adoption of Artificial Intelligence and Analytics in Diagnostic Imaging
  • Strong Growth Potential in Innovative Novel Technologies: Spatial Transcriptomics Technology
  • Strategic Collaborations a Way to Bolstering Innovation and Market Dominance

Key Companies Profiled

Abbott Laboratories, Agilent Technologies, Abcam Plc, Bio-Rad Laboratories, Inc., Danaher Corporation, Fluidigm Corporation, Olympus Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Hamamatsu Photonics K.K., Becton, Dickinson and Company, Nikon Corporation, PerkinElmer Inc., Shimadzu Corporation, and Thermo Fisher Scientific Inc., among others.

Key Questions Answered in this Report:


  • What are the various tissue imaging technologies available in the market?
  • What is the current market size and future potential of these technologies?
  • What are the major market drivers, challenges, and opportunities in the global tissue imaging market?
  • How are the novel tissue imaging technologies expected to drive the concept of translational research?
  • What are the guidelines implemented by different government bodies to regulate the approval of tissue imaging technologies?
  • What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
  • Who are the leading players holding dominating shares in the global tissue imaging market, currently?
  • What are the key strategies incorporated by the players of the global tissue imaging market, to sustain the competition and retain their supremacy?  
  • What is the current revenue contribution of different product types and how is it estimated to evolve in the forecast period?
  • What is the current revenue contribution in different applications and how is it estimated to evolve in the forecast period?
  • What is the current demand contribution of different end user types and how is it estimated to evolve in the forecast period?
  • Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global tissue imaging market?

Overview on the Global Tissue Imaging Market

The global tissue imaging market is currently witnessing a significant change in the market landscape. There is rising awareness about early diagnosis and detection of diseases, coupled with a rise in the cases of chronic diseases. Thus, this is leading to potential growth opportunities for the tissue imaging market. Moreover, there is an extensive entry of tech-giants and software companies into the healthcare space. These companies are integrating their expertise in advanced technologies such as artificial intelligence, and machine learning algorithms, among others into the imaging technologies. In addition, the growing prominence of technologies which are enabling precision diagnosis is also bolstering the paradigm shift toward digitization in the tissue imaging domain.

Global Tissue Imaging Market Forecast

The global tissue imaging market was valued to be $14.42 billion in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $37.44 billion by 2030. The industry is growing multifold owing to the rising awareness about early diagnosis and detection of diseases. Tissue imaging domain is currently at the cusp of a major technological shift from non-digital practices to digital practices, due to the advent of digital pathology technologies. Tissue imaging domain is also currently exploring the potential of technologies such as imaging flow cytometry and mass spectroscopy imaging, for diagnostic, translational, and theragnostic applications. Hence, it is anticipated that these trends will have a significant impact on the tissue imaging market in the next 10 years, and the market will grow multifold.

Competitive Landscape

The global tissue imaging market is dominated by a plethora of life sciences companies that can be categorized as developers of consumables including kits, reagents, and manufacturers of platforms such as digital pathology scanners and mass spectroscopy imaging systems. Companies are continuously collaborating with research and medical institutions to expand the digital diagnosis or the digital pathology space.

In the last five years (January 2015-February 2020), the market witnessed approximately 303 notable key developments. These included 119 product launches, and enhancements 108 synergistic activities, 31 mergers, and acquisitions, 24 regulatory and legal activities, among others. Most of the companies are significantly undertaking synergistic activities and product launches to not only expand their global footprint but also to leverage technologies and products offered by other companies in a bid to consolidate the marketplace. Therefore, synergistic activities constitute the dominant contributors’ strategies.

The key players contributing to the global tissue imaging market are Abbott Laboratories, Agilent Technologies, Abcam Plc, Bio-Rad Laboratories, Inc., Danaher Corporation, Fluidigm Corporation, Olympus Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Hamamatsu Photonics K.K., Becton, Dickinson and Company, Nikon Corporation, PerkinElmer Inc., Shimadzu Corporation, and Thermo Fisher Scientific Inc., among others.


Enterprise License customers will receive an Excel spreadsheet containing additional data.


Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio SB
  • Danaher Corporation
  • Fluidigm Corporation
  • Merck KGaA
  • Olympus Corporation


Executive Summary
1 Technology Definition
1.1 Inclusion and Exclusion Criteria
1.1.1 Inclusions
1.1.2 Exclusions
2 Research Scope
2.1 Key Questions Answered in the Report
2.2 Forecast Period Selection Criteria
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
3.3 Data Sources and Categorization
3.4 Criteria for Company Profiles
3.5 Market Estimation and Forecast Methodology
3.6 Data Triangulation
3.7 Assumptions and Limitations
4 Industry Insights
4.1 Industry Ecosystem
4.1.1 Tissue Imaging Products Manufacturers
4.1.2 Tissue Imaging Products Vendors
4.1.3 Contract Manufacturers
4.1.4 Distributors
4.2 Supply Chain Analysis
4.3 Patent Analysis
4.4 Legal Requirements and Regulations
4.4.1 Regulatory Framework in the U.S.
4.4.2 Regulatory Framework in Europe
4.4.3 Regulatory Framework in Japan
4.4.3.1 Regulatory Pathway for Medical Device Registration in Japan:
4.4.4 Regulatory Framework in China
4.4.4.1 Classification of Medical Devices in China
4.4.4.2 Regulation Changes in China:
4.4.5 Regulatory Framework in Other Countries
4.4.5.1 Regulatory Framework in India
4.4.5.2 Regulatory Framework in Latin America
4.4.5.3 Regulatory Framework in Middle East and Africa
4.4.6 Consortiums, Associations, and Regulatory Bodies
4.5 Role of Tissue Imaging in Translational Research
4.6 Role of Tissue Imaging in COVID-19 Scenario
5 Competitive Landscape
5.1 Key Developments and Strategies
5.1.1 Digital Pathology Technology
5.1.1.1 Partnerships, Alliances, and Business Expansions
5.1.1.2 New Offerings
5.1.1.3 Regulatory and Legal Developments
5.1.1.4 Acquisitions
5.1.1.5 Procurement and Sale Activities
5.1.1.6 Funding Activities
5.1.2 Flow Cytometry Technology
5.1.2.1 New Offerings
5.1.2.2 Partnerships, Alliances, and Business Expansions
5.1.2.3 Procurement and Sale Activities
5.1.2.4 Acquisitions
5.1.2.5 Regulatory and Legal Developments
5.1.2.6 Funding Activities
5.1.3 Immunohistochemistry Technology
5.1.3.1 New Offerings
5.1.3.2 Partnerships, Alliances, and Business Expansions
5.1.3.3 Acquisitions
5.1.3.4 Procurement and Sales Activities
5.1.4 In- Situ Hybridization Technology
5.1.4.1 New Offerings
5.1.4.2 Partnerships, Alliances, and Business Expansions
5.1.4.3 Acquisitions
5.1.5 Mass Spectroscopy Imaging Technology
5.1.5.1 New Offerings
5.1.5.2 Partnerships, Alliances, and Business Expansions
5.1.5.3 Procurement and Sales Activities
5.1.5.4 Acquisitions
5.1.6 Immunofluorescence Technology
5.1.6.1 New Offerings
5.1.6.2 Procurement and Sale Activities
5.1.6.3 Partnerships, Alliances, and Business Expansions
5.1.6.4 Acquisitions
5.1.6.5 Regulatory and Legal Developments
5.1.6.6 Funding Activities
5.2 Market Share Analysis
5.3 Growth Share Matrix
5.3.1 Growth Share Matrix (Digital Pathology)
5.3.2 Growth Share Matrix (Flow Cytometry)
5.3.3 Growth Share Matrix (Mass Spectroscopy Imaging)
5.3.4 Growth Share Matrix (In Situ Hybridization)
5.3.5 Growth Share Matrix (Immunohistochemistry)
5.3.6 Growth Share Matrix (Immunofluorescence)
5.4 Business Model Analysis
5.4.1 Key Strategies Adopted
5.4.1.1 Consumables, a Source of Recurring Revenue Stream- Utilizing the Razor/Blade Strategy
5.4.1.2 Organic Opportunities and Acquired Growth Opportunities
5.4.1.3 Investment on R&D
5.4.2 Key Challenges Faced
6 Global Tissue Imaging Market Scenario
6.1 Assumptions and Limitations
6.2 Key Findings
6.3 Potential Opportunities – Tissue Imaging Technologies
6.3.1 Adoption of Artificial Intelligence and Analytics in Diagnostic Imaging
6.3.2 Strong Growth Potential in Innovative Novel Technologies: Spatial Transcriptomics Technology
6.3.3 Strategic Collaborations a Way to Bolstering Innovation and Market Dominance
6.4 Global Tissue Imaging Market Size and Forecast
6.4.1 Market Drivers
6.4.1.1 Rising Incidence of Disorders Inciting the Use of Tissue Imaging
6.4.1.2 Integration of Digital Technology with Imaging Technologies
6.4.1.3 Role of Early Diagnosis in the Detection of Chronic Ailments Using Modern Imaging Techniques
6.4.1.4 Shifting Focus Toward Value-Oriented Healthcare Model
6.4.2 Market Restraints
6.4.2.1 Decline in Funds for Research & Development
6.4.2.2 Stringent Regulatory Requirements
7 Global Tissue Imaging Market (by Technology), 2019-2030
7.1 Mass Spectroscopy Imaging
7.1.1 Market Share Analysis – Mass Spectroscopy Imaging (by Company)
7.1.1.1 MALDI Imaging
7.1.1.2 DESI Imaging
7.1.1.3 SIMS Imaging
7.2 Flow Cytometry
7.2.1 Market Share Analysis – Flow Cytometry (by Company)
7.3 Immunohistochemistry (IHC)
7.3.1 Market Share Analysis – Immunohistochemistry (by Company)
7.4 Digital Pathology
7.4.1 Market Share Analysis – Digital Pathology (by Company)
7.5 Immunofluorescence
7.5.1 Market Share Analysis – Immunofluorescence (by Company)
7.5.1.1 Secondary Immunofluorescence/In-Direct Immunofluorescence
7.5.1.2 Primary/ Direct Immunofluorescence
7.6 In Situ Hybridization (ISH)
7.6.1 Market Share Analysis – In Situ Hybridization (by Company)
7.6.1.1 Fluorescence In-Situ Hybridization (FISH)
7.6.1.1.1 DNA Fluorescence In-Situ Hybridization
7.6.1.1.2 RNA Fluorescence In-Situ Hybridization
7.6.1.1.3 Protein Fluorescence In-Situ Hybridization
7.6.1.2 Chromogenic In-Situ Hybridization (CISH)
8 Global Tissue Imaging Market (by Product), 2019-2030
8.1 Platforms
8.1.1 Mass Spectroscopy Imaging (MSI) platforms
8.1.1.1 MALDI Imaging platforms
8.1.1.2 DESI Imaging Platforms
8.1.1.3 SIMS Imaging
8.1.2 Flow Cytometry Analyzers
8.1.3 Digital Pathology Scanners
8.1.4 Immunohistochemistry Detection Systems
8.1.5 In-Situ Hybridization Platforms
8.1.6 Immunofluorescence Imaging Analysis Systems
8.1.7 Tissue Microarray Platforms
8.2 Microscopes
8.2.1 Optical Microscopes
8.2.1.1 Compound Microscopes
8.2.1.2 Digital Microscopes
8.2.1.3 Fluorescence Microscopes
8.2.1.4 Others
8.2.2 Electron Microscopes
8.2.2.1 Scanning Electron Microscopes (SEM)
8.2.2.2 Transmission Electron Microscopes (TEM)
8.2.3 Scanning Probe Microscopes
8.2.4 Others
8.3 Consumables
8.3.1 Antibodies & Reagents
8.3.2 Kits
8.3.3 Probes
8.3.4 Others
8.4 Software
8.5 Accessories
9 Global Tissue Imaging Market (by Therapeutic Application), 2019-2030
9.1 Disease Research
9.1.1 Oncology Disease Research
9.1.1.1 Breast Cancer Research
9.1.1.1.1 Breast Cancer Research (by Product Type)
9.1.1.2 Lung Cancer Research
9.1.1.2.1 Lung Cancer Research (by Product Type)
9.1.1.3 Colorectal Cancer Research
9.1.1.3.1 Colorectal Cancer Research (by Product Type)
9.1.1.4 Liver Cancer Research
9.1.1.4.1 Liver Cancer Research (by Product Type)
9.1.1.5 Prostate Cancer Research
9.1.1.5.1 Prostate Cancer Research (by Product Type)
9.1.1.6 Research of Other Cancer Types
9.1.1.6.1 Research of Other Cancer Types (by Product Type)
9.1.2 Infectious Disease Research
9.1.2.1 Infectious Disease Research (by Product Type)
9.1.3 Neurology Disease Research
9.1.3.1 Neurology Disease Research (by Product Type)
9.1.4 Cardiology Disease Research
9.1.4.1 Cardiology Disease Research (by Product Type)
9.1.5 Immunology Disease Research
9.1.5.1 Immunology Disease Research (by Product Type)
9.1.6 Other Diseases Research
9.1.6.1 Research of Other Disease Types (by Product Type)
9.2 Diagnostics
9.2.1 Oncology Diagnostics
9.2.1.1 Breast Cancer Diagnostics
9.2.1.1.1 Breast Cancer Diagnosis (by Product Type)
9.2.1.2 Lung Cancer Diagnostics
9.2.1.2.1 Lung Cancer Diagnosis (by Product Type)
9.2.1.3 Colorectal Cancer Diagnostics
9.2.1.3.1 Colorectal Cancer Diagnosis (by Product Type)
9.2.1.4 Liver Cancer Diagnostics
9.2.1.4.1 Liver Cancer Diagnosis (by Product Type)
9.2.1.5 Prostate Cancer Diagnosis
9.2.1.5.1 Prostate Cancer Diagnosis (by Product Type)
9.2.1.6 Diagnosis of Other Cancer Types
9.2.1.6.1 Other Cancer Types Diagnostic Activities (by Product Type)
9.2.2 Infectious Diseases Diagnostics
9.2.2.1 Infectious Disease Diagnostics (by Product Type)
9.2.3 Neurology Disease Diagnostics
9.2.3.1 Neurology Disease Diagnostics (by Product Type)
9.2.4 Cardiology Disease Diagnostics
9.2.4.1 Cardiology Disease Diagnosis (by Product Type)
9.2.5 Immunology Disease Diagnostics
9.2.5.1 Immunology Disease Diagnostics (by Product Type)
9.2.6 Other Diseases Diagnostics
9.2.6.1 Diagnostics of Other Disease Types (by Product Type)
10 Global Tissue Imaging Market (by Region), 2019-2030
10.1 North America
10.1.1 U.S.
10.1.1.1 U.S. Tissue Imaging Market (by Technology Type), 2019-2030
10.1.1.2 U.S Tissue Imaging Market (by Product Type), 2019-2030
10.1.2 Canada
10.1.2.1 Canada Tissue Imaging Market (by Technology Type), 2019-2030
10.1.2.2 Canada Tissue Imaging Market (by Product Type), 2019-2030
10.2 Europe
10.2.1 Germany
10.2.1.1 Germany Tissue Imaging Market (by Technology Type), 2019-2030
10.2.1.2 Germany Tissue Imaging Market (by Product Type), 2019-2030
10.2.2 France
10.2.2.1 France Tissue Imaging Market (by Technology Type), 2019-2030
10.2.2.2 France Tissue Imaging Market (by Product Type), 2019-2030
10.2.3 U.K.
10.2.3.1 U.K Tissue Imaging Market (by Technology Type), 2019-2030
10.2.3.2 U.K. Tissue Imaging Market (by Product Type), 2019-2030
10.2.4 Italy
10.2.4.1 Italy Tissue Imaging Market (by Technology Type), 2019-2030
10.2.4.2 Italy Tissue Imaging Market (by Product Type), 2019-2030
10.2.5 Spain
10.2.5.1 Spain Tissue Imaging Market (by Technology Type), 2019-2030
10.2.5.2 Spain Tissue Imaging Market (by Product Type), 2019-2030
10.2.6 Switzerland
10.2.6.1 Switzerland Tissue Imaging Market (by Technology Type), 2019-2030
10.2.6.2 Switzerland Tissue Imaging Market (by Product Type), 2019-2030
10.2.7 Netherlands
10.2.7.1 Netherlands Tissue Imaging Market (by Technology Type), 2019-2030
10.2.7.2 Netherlands Tissue Imaging Market (by Product Type), 2019-2030
10.2.8 Rest-of-Europe
10.2.8.1 Rest-of-Europe Tissue Imaging Market (by Technology Type), 2019-2030
10.2.8.2 Rest-of-Europe Tissue Imaging Market (by Product Type), 2019-2030
10.3 Asia-Pacific
10.3.1 Japan
10.3.1.1 Japan Tissue Imaging Market (by Technology Type), 2019-2030
10.3.1.2 Japan Tissue Imaging Market (by Product Type), 2019-2030
10.3.2 China
10.3.2.1 China Tissue Imaging Market (by Technology Type), 2019-2030
10.3.2.2 China Tissue Imaging Market (by Product Type), 2019-2030
10.3.3 India
10.3.3.1 India Tissue Imaging Market (by Technology Type), 2019-2030
10.3.3.2 India Tissue Imaging Market (by Product Type), 2019-2030
10.3.4 Australia
10.3.4.1 Australia Tissue Imaging Market (by Technology Type), 2019-2030
10.3.4.2 Australia Tissue Imaging Market (by Product Type), 2019-2030
10.3.5 South Korea
10.3.5.1 South Korea Tissue Imaging Market (by Technology Type), 2019-2030
10.3.5.2 South Korea: Tissue Imaging Market (by Product Type), 2019-2030
10.3.6 Rest-of-Asia-Pacific
10.3.6.1 Rest-of-Asia-Pacific Tissue Imaging Market (by Technology Type),  2019-2030
10.3.6.2 Rest-of-Asia-Pacific Tissue Imaging Market (by Product Type), 2019-2030
11 Global Tissue Imaging Market (by End User), 2020-2030
11.1 Biotechnology Companies
11.1.1 Biotechnology Companies (by Technology Type) in Tissue Imaging Market
11.2 Pharmaceutical Companies
11.2.1 Pharmaceutical Companies (by Technology type) in Tissue Imaging Market
11.3 Contract Research Organizations (CROs)
11.3.1 Contract Research Organizations (by Technology type) in Tissue Imaging Market
11.4 Academic and Research Institutions
11.4.1 Academic and Research Institutions, (by Technology Type) in Tissue Imaging Market
11.5 Hospitals and Diagnostic Laboratories
11.5.1 Hospitals and Diagnostic Laboratories, (by Technology Type) in Tissue Imaging Market
12 Company Profiles
12.1 Overview
12.2 Abbott Laboratories
12.2.1 Company Overview
12.2.2 Role of Abbott Laboratories in the Global Tissue Imaging Market
12.2.3 Financials
12.2.3.1 Key Insights About the Financial Health of the Company
12.2.4 SWOT Analysis
12.3 Abcam Plc.
12.3.1 Company Overview
12.3.2 Role of Abcam Plc in the Global Tissue Imaging Market
12.3.3 Financials
12.3.3.1 Key Insights About the Financial Health of the Company
12.3.4 SWOT Analysis
12.4 Agilent Technologies, Inc.
12.4.1 Company Overview
12.4.2 Role of Agilent Technologies, Inc. in the Global Tissue Imaging Market
12.4.3 Financials
12.4.3.1 Key Insights About Financial Health of the Company
12.4.4 SWOT Analysis
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Company Overview
12.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Tissue Imaging Market
12.5.3 Financials
12.5.3.1 Key Insights About Financial Health of the Company
12.5.4 SWOT Analysis
12.6 Bio SB
12.6.1 Company overview
12.6.2 Role of Bio SB in the Global Tissue Imaging Market
12.6.3 SWOT Analysis
12.7 Biocare Medical
12.7.1 Company overview
12.7.2 Role of Biocare Medical in the Global Tissue Imaging Market
12.7.3 SWOT Analysis
12.8 Becton, Dickinson and Company
12.8.1 Company Overview
12.8.2 Role of Becton, Dickinson and Company in the Global Tissue Imaging Market
12.8.3 Financials
12.8.3.1 Key Insights About the Financial Health of the Company
12.8.4 SWOT Analysis
12.9 Danaher Corporation
12.9.1 Company Overview
12.9.2 Role of Danaher Corporation in the Global Tissue Imaging Market
12.9.3 Financials
12.9.3.1 Key Insights About the Financial Health of the Company
12.9.4 SWOT Analysis
12.10   Fluidigm Corporation
12.10.1 Company Overview
12.10.2 Role of Fluidigm Corporation in the Global Tissue Imaging Market
12.10.3 Financials
12.10.3.1 Key Insights About the Financial Health of the Company
12.10.4 SWOT Analysis
12.11   F. Hoffmann-La Roche Ltd
12.11.1 Company Overview
12.11.2 Role of F. Hoffmann-La Roche Ltd in the Global Tissue Imaging Market
12.11.3 Financials
12.11.3.1 Key Insights About the Financial Health of the Company
12.11.4 SWOT Analysis
12.12   Hamamatsu Photonics K.K.
12.12.1 Company Overview
12.12.2 Role of Hamamatsu Photonics K.K.  in the Global Tissue Imaging Market
12.12.3 Financials
12.12.3.1 Key Insights About the Financial Health of the Company
12.12.4 SWOT Analysis
12.13   Nikon Corporation.
12.13.1 Company Overview
12.13.2 Role of Nikon Corporation. in the Global Tissue Imaging Market
12.13.3 Financials
12.13.3.1 Key Insights About the Financial Health of the Company
12.13.4 SWOT Analysis
12.14   PerkinElmer Inc.
12.14.1 Company Overview
12.14.2 Role of PerkinElmer Inc. in the Global Tissue Imaging Market
12.14.3 Financials
12.14.3.1 Key Insights About the Financial Health of the Company
12.14.4 SWOT Analysis
12.15   Sakura Finetek
12.15.1 Company overview
12.15.2 Role of Sakura Finetek in the Global Tissue Imaging Market
12.15.3 SWOT Analysis
12.16   LifeSpan BioSciences, Inc.
12.16.1 Company overview
12.16.2 Role of LifeSpan BioSciences, Inc. in the Global Tissue Imaging Market
12.16.3 SWOT Analysis
12.17   Merck KGaA
12.17.1 Company Overview
12.17.2 Role of Merck KGaA in the Global Tissue Imaging Market
12.17.3 Financials
12.17.3.1 Key Insights About the Financial Health of the Company
12.17.4 SWOT Analysis
12.18   Olympus Corporation
12.18.1 Company Overview
12.18.2 Role of Olympus Corporation in the Global Tissue Imaging Market
12.18.3 Financials
12.18.3.1 Key Insights About the Financial Health of the Company
12.18.4 SWOT Analysis
12.19   Thermo Fisher Scientific Inc.
12.19.1 Company Overview
12.19.2 Role of Thermo Fisher Scientific Inc. in the Global Tissue Imaging Market
12.19.3 Financials
12.19.3.1 Key Insights About the Financial Health of the Company
12.19.4 SWOT Analysis
12.20   Shimadzu Corporation
12.20.1 Company Overview
12.20.2 Role of Shimadzu Corporation in the Global Tissue Imaging Market
12.20.3 Financials
12.20.3.1 Key Insights About the Financial Health of the Company
12.20.4 SWOT Analysis
12.21  Vector Laboratories
12.21.1 Company overview
12.21.2 Role of Vector Laboratories in the Global Tissue Imaging Market
12.21.3 SWOT Analysis
List of Tables
Table 1: Impact Analysis of Market Drivers
Table 2: Impact Analysis of Market Restraints
Table 3: Leading Players of Global Tissue Imaging Market
Table 4.1: List of Associations/Consortiums/Regulatory Bodies with Year of Establishment, and Region
Table 4.2: Tissue Imaging Technologies that can be used for Translational Research
Table 6.1: Number of Active Development Programs
Table 6.2: Impact Analysis of Market Drivers
Table 6.3: Impact Analysis of Market Restraints
Table 7.1: Comparison of Mass Spectroscopy Imaging Techniques
Table 9.1: Number of Pipeline Breast Cancer Drug Candidates Possessed by Leading Companies
Table 9.2: Number of Pipeline Lung Cancer Drug Candidates Possessed by Leading Companies
Table 9.3: Number of Pipeline Liver Cancer Drug Candidates Possessed by Leading Companies
Table 9.4: Scenario-based Tissue Imaging Technique Incorporated for Diagnosis of Infectious Diseases
Table 9.5: Tissue Imaging techniques Incorporated for Different Types of Neurological Disorders
Table 9.6: Tissue Imaging techniques Incorporated for Different Types of Cardiology Disorders
Table 9.7: Tissue Imaging techniques Incorporated for Different Types of Immunology Disorders
Table 12.1: Abbott Laboratories: Market Share
Table 12.2: Abbott Laboratories: Relatable Segments Information
Table 12.3: Abcam Plc: Market Share
Table 12.4: Agilent Technologies, Inc.: Market Share
Table 12.5: Agilent Technologies, Inc.: Relatable Segments Information
Table 12.6: Bio-Rad Laboratories, Inc.: Market Share
Table 12.7: Becton, Dickinson and Company.: Market Share
Table 12.8: Becton, Dickinson and Company: Relatable Segments Information
Table 12.9: Danaher Corporation.: Market Share
Table 12.10: Danaher Corporation: Relatable Segments Information
Table 12.11: Fluidigm Corporation.: Market Share
Table 12.12: F. Hoffmann-La Roche Ltd: Market Share
Table 12.13: F. Hoffmann-La Roche Ltd: Relatable Segments Information
Table 12.14: Hamamatsu Photonics K.K.: Market Share
Table 12.15: Hamamatsu Photonics K.K.: Relatable Segments Information
Table 12.16: Nikon Corporation.: Market Share
Table 12.17: Nikon Corporation: Relatable Segments Information
Table 12.18: PerkinElmer Inc.: Market Share
Table 12.19: PerkinElmer Inc.: Relatable Segments Information
Table 12.20: Merck KGaA: Market Share
Table 12.21: Merck KGaA: Relatable Segments Information
Table 12.22: Olympus Corporation: Market Share
Table 12.23: Olympus Corporation: Relatable Segments Information
Table 12.24: Thermo Fisher Scientific Inc.: Market Share
Table 12.25: Shimadzu Corporation: Market Share
List of Figures
Figure 1: Global Tissue Imaging Market – Opportunity
Figure 2: Key Strategies Incorporated by Players of Global Tissue Imaging Market
Figure 3: Key Strategies Incorporated by Players of Global Tissue Imaging Market, (By Technology Type)
Figure 4: Global Tissue Imaging Market (by Technology), 2019 and 2030
Figure 5: Global Tissue Imaging Market (by Product), 2019 and 2030
Figure 2.1: Global Tissue Imaging Market Segmentation
Figure 3.1: Research Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Assumptions and Limitations
Figure 4.1: Global Tissue Imaging Market Supply Chain Analysis
Figure 4.2: Global Tissue Imaging Market: Patent Analysis (by Technology), April 2015- April 2020
Figure 4.3: Global Tissue Imaging Market: Patent Analysis (by Flow Cytometry), April 2015-April 2020
Figure 4.4: Global Tissue Imaging Market: Patent Analysis (by Immunofluorescence), April 2015-April 2020
Figure 4.5: Global Tissue Imaging Market: Patent Analysis (by Immunohistochemistry), April 2015-April 2020
Figure 4.6: Global Tissue Imaging Market: Patent Analysis (by In Situ Hybridization), April 2015-April 2020
Figure 4.7: Global Tissue Imaging Market: Patent Analysis (by Digital Pathology), April 2015-April 2020
Figure 4.8: Global Tissue Imaging Market: Patent Analysis (by Mass Spectrometry Imaging), April 2015-April 2020
Figure 4.9: Regulatory Process for Medical Devices in the U.S.
Figure 4.10: MDR Transitional Provisions
Figure 4.11: MDR Timeline
Figure 5.1: Share of Key Developments and Strategies, January 2015 – February 2020
Figure 5.2: Share of Key Developments and Strategies, by Technology, January 2015 – February 2020
Figure 5.3: Share of Key Developments and Strategies, January 2015 – February 2020
Figure 5.4: Partnerships, Collaborations, and Joint Ventures Share (by Company), January 2015 – February 2020
Figure 5.5: Product Launches Share (by Company), January 2015 – February 2020
Figure 5.6: Regulatory and Legal Developments Share (by Company), January 2015 – February 2020
Figure 5.7: Acquisitions Share (by Company), January 2015 – February 2020
Figure 5.8: Share of Key Developments and Strategies, January 2015 – February 2020
Figure 5.9: Product Launches Share (by Company), January 2015 – February 2020
Figure 5.10: Partnerships, Collaborations, and Joint Ventures Share (by Company),  January 2015 – February 2020
Figure 5.11: Procurement and Sales Activities Share (by Company), January 2015 – February 2020
Figure 5.12: Regulatory and Legal Development Share (by Company), January 2015 – February 2020
Figure 5.13: Share of Key Developments and Strategies, January 2015 – February 2020
Figure 5.14: Product Launches Share (by Company), January 2015 – February 2020
Figure 5.15: Partnerships, Collaborations and Joint Ventures Share (by Company), January 2015 – February 2020
Figure 5.16: Acquisitions Share (by Company), January 2015 – February 2020
Figure 5.17: Share of Key Developments and Strategies, January 2015 – February 2020
Figure 5.18: Product Launches Share (by Company), January 2015 – February 2020
Figure 5.19: Partnerships, Collaborations and Joint Ventures Share (by Company), January 2015 – February 2020
Figure 5.20: Share of Key Developments and Strategies, January 2015 – February 2020
Figure 5.21: Product Launches Share (by Company), January 2015 – February 2020
Figure 5.22: Partnerships, Collaborations and Joint Ventures Share (by Company), January 2015 – February 2020
Figure 5.23: Share of Key Developments and Strategies, January 2015 – February 2020
Figure 5.24: Product Launches Share (by Company), January 2015 – February 2020
Figure 5.25: Procurement and Sale Activities Share (by Company), January 2015 – February 2020
Figure 5.26: Partnerships, Collaborations and Joint Ventures Share (by Company), January 2015 – February 2020
Figure 5.27: Acquisitions Share (by Company), January 2015 – February 2020
Figure 5.28: Market Share Analysis (by Companies), 2018 and 2019
Figure 5.29: Growth Share Matrix for Tissue Imaging Market (Digital Pathology), 2019-2030
Figure 5.30: Growth Share Matrix for Global Tissue Imaging Market (Flow Cytometry), 2019-2030
Figure 5.31: Growth Share Matrix for Global Tissue Imaging Market (Mass Spectroscopy Imaging), 2019-2030
Figure 5.32: Growth Share Matrix for Global Tissue Imaging Market (In Situ Hybridization), 2019-2030
Figure 5.33: Growth Share Matrix for Tissue Imaging Market (Immunohistochemistry), 2019-2030
Figure 5.34: Growth Share Matrix for Tissue Imaging Market (Immunofluorescence), 2019-2030
Figure 5.35: Danaher Corporation’s Revenue Composition
Figure 6.1: Global Tissue Imaging Market Incremental Revenue Opportunity, 2020-2030
Figure 6.2: Global Tissue Imaging Market Size and Forecast, 2019-2030
Figure 7.1: Revenue Contributions of Different Technologies, 2019 and 2030
Figure 7.2: Global Tissue Imaging Market (by Mass Spectroscopy Imaging), 2019-2030
Figure 7.3: Market Share Analysis – Mass Spectroscopy Imaging (by Company), 2018
Figure 7.4: Market Share Analysis – Mass Spectroscopy Imaging (by Company), 2019
Figure 7.5: Global Tissue Imaging Market (by Mass Spectroscopy Imaging), 2019 and 2030
Figure 7.6: Global Tissue Imaging Market (MALDI Imaging), 2019-2030
Figure 7.7: Global Tissue Imaging Market (by DESI Imaging), 2019-2030
Figure 7.8: Global Tissue Imaging Market (by SIMS Imaging), 2019-2030
Figure 7.9: Global Tissue Imaging Market (by Flow Cytometry), 2019-2030
Figure 7.10: Market Share Analysis – Flow Cytometry (by Company), 2018
Figure 7.11: Market Share Analysis – Flow Cytometry (by Company), 2019
Figure 7.12: Global Tissue Imaging Market (by Immunohistochemistry), 2019-2030
Figure 7.13: Market Share Analysis – Immunohistochemistry (by Company), 2018
Figure 7.14: Market Share Analysis – Immunohistochemistry (by Company), 2019
Figure 7.15: Global Tissue Imaging Market (by Digital Pathology), 2019-2030
Figure 7.16: Market Share Analysis – Digital Pathology (by Company), 2018
Figure 7.17: Market Share Analysis – Digital Pathology (by Company), 2019
Figure 7.18: Global Tissue Imaging Market (by Immunofluorescence), 2019-2030
Figure 7.19: Market Share Analysis – Immunofluorescence (by Company), 2018
Figure 7.20: Market Share Analysis – Immunofluorescence (by Company), 2019
Figure 7.21: Global Tissue Imaging Market (by Immunofluorescence), 2019 and 2030
Figure 7.22: Global Tissue Imaging Market (by Secondary Immunofluorescence/In-Direct Immunofluorescence), 2019-2030
Figure 7.23: Global Tissue Imaging Market (Primary/Direct Immunofluorescence),  2019-2030
Figure 7.24: Global Tissue Imaging Market (by In Situ Hybridization), 2019-2030
Figure 7.25: Market Share Analysis – In Situ Hybridization (by Company), 2018
Figure 7.26: Market Share Analysis – In Situ Hybridization (by Company), 2019
Figure 7.27: Global Tissue Imaging Market (by In Situ Hybridization), 2019 and 2030
Figure 7.28: Global Tissue Imaging Market (by Fluorescence In-Situ Hybridization), 2019-2030
Figure 7.29: Global Tissue Imaging Market (by Fluorescence In-Situ Hybridization), 2019 and 2030
Figure 7.30: Global Tissue Imaging Market (DNA Fluorescence In-Situ Hybridization), 2019-2030
Figure 7.31: Global Tissue Imaging Market (by RNA Fluorescence In-Situ Hybridization), 2019-2030
Figure 7.32: Global Tissue Imaging Market (by Protein Fluorescence In-Situ Hybridization), 2019-2030
Figure 7.33: Global Tissue Imaging Market (by Chromogenic In-Situ Hybridization), 2019-2030
Figure 8.1: Revenue Contributions (Products), 2019 and 2030
Figure 8.2: Global Tissue Imaging Market (Platforms), 2019-2030
Figure 8.3: Global Tissue Imaging Market (by Platforms), 2019 and 2030
Figure 8.4: Global Tissue Imaging Market (Mass Spectroscopy Imaging Platforms), 2019-2030
Figure 8.5: Global Tissue Imaging Market (by Mass Spectroscopy Imaging Platform), 2019 and 2030
Figure 8.6: Global Tissue Imaging Market (MALDI Imaging Platforms), 2019-2030
Figure 8.7: Global Tissue Imaging Market (DESI Imaging Platforms), 2019-2030
Figure 8.8: Global Tissue Imaging Market (SIMS Imaging), 2019-2030
Figure 8.9: Global Tissue Imaging Market (Flow Cytometry Analysers), 2019-2030
Figure 8.10: Global Tissue Imaging Market (Digital Pathology), 2019-2030
Figure 8.11: Global Tissue Imaging Market (Immunohistochemistry Detection Systems), 2019-2030
Figure 8.12: Global Tissue Imaging Market (In Situ Hybridization Platforms), 2019-2030
Figure 8.13: Global Tissue Imaging Market (Immunofluorescence Imaging Analysis Systems), 2019-2030
Figure 8.14: Global Tissue Imaging Market (Tissue Microarray Platforms), 2019-2030
Figure 8.15: Global Tissue Imaging Market (Microscopes), 2019-2030
Figure 8.16: Global Tissue Imaging Market (by Microscope), 2019 and 2030
Figure 8.17: Global Tissue Imaging Market (Optical Microscopes), 2019-2030
Figure 8.18: Global Tissue Imaging Market (by Optical Microscopes), 2019 and 2030
Figure 8.19: Global Tissue Imaging Market (Compound Microscopes), 2019-2030
Figure 8.20: Global Tissue Imaging Market (Digital Microscopes), 2019-2030
Figure 8.21: Global Tissue Imaging Market (Fluorescence Microscopes), 2019-2030
Figure 8.22: Global Tissue Imaging Market (Others), 2019-2030
Figure 8.23: Global Tissue Imaging Market (Electron Microscopes), 2019-2030
Figure 8.24: Global Tissue Imaging Market (by Electron Microscopes), 2019 and 2030
Figure 8.25: Global Tissue Imaging Market (Scanning Electron Microscopes), 2019-2030
Figure 8.26: Global Tissue Imaging Market (Transmission Electron Microscopes),  2019-2030
Figure 8.27: Global Tissue Imaging Market (Scanning Probe Microscopes), 2019-2030
Figure 8.28: Global Tissue Imaging Market (Others), 2019-2030
Figure 8.29: Global Tissue Imaging Market (Consumables), 2019-2030
Figure 8.30: Global Tissue Imaging Market (by Consumables), 2019 and 2030
Figure 8.31: Global Tissue Imaging Market (Antibodies & Reagents), 2019-2030
Figure 8.32: Global Tissue Imaging Market (Kits), 2019-2030
Figure 8.33: Global Tissue Imaging Market (Probes), 2019-2030
Figure 8.34: Global Tissue Imaging Market (Others), 2019-2030
Figure 8.35: Global Tissue Imaging Market (Software), 2019-2030
Figure 8.36: Global Tissue Imaging Market (Accessories), 2019-2030
Figure 9.1: Revenue Contribution of Disease Research vs Diagnostics, 2019 and 2030
Figure 9.2: Global Disease Research Tissue Imaging Market, 2019-2030
Figure 9.3: Revenue Contributions of Different Therapeutic Applications to Disease Research Revenue, 2019 and 2030
Figure 9.4: Global Oncology Disease Research Tissue Imaging Market, 2019-2030
Figure 9.5: Revenue Contributions of Different Types of Cancer, 2019 and 2030
Figure 9.6: Global Breast Cancer Research Tissue Imaging Market, 2019-2030
Figure 9.7: Global Breast Cancer Research Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.8: Global Lung Cancer Research Tissue Imaging Market, 2019-2030
Figure 9.9: Global Lung Cancer Research Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.10: Global Colorectal Cancer Research Tissue Imaging Market, 2019-2030
Figure 9.11: Global Colorectal Cancer Research Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.12: Global Liver Cancer Research Tissue Imaging Market, 2019-2030
Figure 9.13: Global Liver Cancer Research Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.14: Global Prostate Cancer Research Tissue Imaging Market, 2019-2030
Figure 9.15: Global Prostate Cancer Research Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.16: Global Research of Other Cancer Types Tissue Imaging Market, 2019-2030
Figure 9.17: Global Research of Other Cancer Types Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.18: Global Infectious Disease Research Tissue Imaging Market, 2019-2030
Figure 9.19: Global Infectious Disease Research Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.20: Global Neurology Disease Research Tissue Imaging Market, 2019-2030
Figure 9.21: Global Neurology Disease Research Tissue Imaging Market, (by Product Type), 2019-2030
Figure 9.22: Global Cardiology Disease Research Tissue Imaging Market, 2019-2030
Figure 9.23: Global Cardiology Disease Research Tissue Imaging Market (by Product Types), 2019-2030
Figure 9.24: Global Immunology Disease Research Tissue Imaging Market, 2019-2030
Figure 9.25: Global Immunology Disease Research Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.26: Global Research of Other Disease Types Tissue Imaging Market, 2019-2030
Figure 9.27: Global Research of Other Disease Types Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.28: Global Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.29: Revenue Contributions of Different Therapeutic Applications to Diagnostics Revenue, 2019 and 2030
Figure 9.30: Global Oncology Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.31: Revenue Contributions of Different Types of Cancer, 2019 and 2030
Figure 9.32: Global Breast Cancer Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.33: Global Breast Cancer Diagnostic Tissue Imaging Market (by Product),  2019-2030
Figure 9.34: Global Lung Cancer Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.35: Global Lung Cancer Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.36: Global Colorectal Cancer Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.37: Global Colorectal Cancer Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.38: Global Liver Cancer Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.39: Global Liver Cancer Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.40: Global Prostate Cancer Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.41: Global Prostate Cancer Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.42: Global Other Cancer Types Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.43: Global Other Cancer Types Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.44: Global Infectious Disease Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.45: Global Infectious Disease Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.46: Global Neurology Disease Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.47: Global Neurology Disease Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.48: Global Cardiology Disease Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.49: Global Cardiology Disease Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.50: Global Immunology Disease Diagnostic Tissue Imaging Market, 2019-2030
Figure 9.51: Global Immunology Disease Diagnostic Tissue Imaging Market (by Product Type), 2019-2030
Figure 9.52: Global Other Disease Diagnostics Tissue Imaging Market, 2019-2030
Figure 9.53: Global Other Disease Types Diagnostics Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.1: Global Tissue Imaging Market (by Region)
Figure 10.2: Revenue Contributions Different Regions, 2019 and 2030
Figure 10.3: North America Tissue Imaging Market, 2019-2030
Figure 10.4: North America: Market Dynamics
Figure 10.5: Revenue Contributions of Different Countries in North America,  2019 and 2030
Figure 10.6: U.S. Tissue Imaging Market, 2019-2030
Figure 10.7: U.S. Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.8: U.S Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.9: Canada Tissue Imaging Market, 2019-2030
Figure 10.10: Canada Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.11: Canada Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.12: Europe Tissue Imaging Market, 2019-2030
Figure 10.13: Europe: Market Dynamics
Figure 10.14: Revenue Contributions Different Countries in Europe, 2019 and 2030
Figure 10.15: Germany Tissue Imaging Market, 2019-2030
Figure 10.16: Germany Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.17: Germany Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.18: France Tissue Imaging Market, 2019-2030
Figure 10.19: France Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.20: France Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.21: U.K. Tissue Imaging Market, 2019-2030
Figure 10.22: U.K Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.23: U.K. Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.24: Italy Tissue Imaging Market, 2019-2030
Figure 10.25: Italy Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.26: Italy Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.27: Spain Tissue Imaging Market, 2019-2030
Figure 10.28: Spain Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.29: Spain Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.30: Switzerland Tissue Imaging Market, 2019-2030
Figure 10.31: Switzerland Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.32: Switzerland Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.33: Netherlands Tissue Imaging Market, 2019-2030
Figure 10.34: Netherlands Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.35: Netherlands Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.36: Rest-of-Europe Tissue Imaging Market, 2019-2030
Figure 10.37: Rest-of-Europe Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.38: Rest-of-Europe Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.39: Asia-Pacific Tissue Imaging Market, 2019-2030
Figure 10.40: Asia-Pacific: Market Dynamics
Figure 10.41: Revenue Contributions Different Countries in Asia-Pacific, 2019 and 2030
Figure 10.42: Japan Tissue Imaging Market, 2019-2030
Figure 10.43: Japan Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.44: Japan Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.45: China Tissue Imaging Market, 2019-2030
Figure 10.46: China Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.47: China Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.48: India Tissue Imaging Market, 2019-2030
Figure 10.49: India Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.50: India Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.51: Australia Tissue Imaging Market, 2019-2030
Figure 10.52: Australia Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.53: Australia Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.54: South Korea Tissue Imaging Market, 2019-2030
Figure 10.55: South Korea Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.56: South Korea: Tissue Imaging Market (by Product Type), 2019-2030
Figure 10.57: Rest-of-Asia-Pacific Tissue Imaging Market, 2019-2030
Figure 10.58: Rest-of-Asia-Pacific Tissue Imaging Market (by Technology Type), 2019-2030
Figure 10.59: Rest-of-Asia-Pacific Tissue Imaging Market (by Product Type), 2019-2030
Figure 11.1: Revenue Contribution of Different End-Users, 2019 and 2030
Figure 11.2: Global Tissue Imaging Market (by Biotechnology Companies), 2019-2030
Figure 11.3: Biotechnology Companies (by Technology Type) in Tissue Imaging Market
Figure 11.4: Global Tissue Imaging Market (by Pharmaceutical Companies), 2019-2030
Figure 11.5: Pharmaceutical Companies (by Technology type) in Tissue Imaging Market
Figure 11.6: Global Tissue Imaging Market (by Contract Research Organizations),  2019-2030
Figure 11.7: Contract Research Organizations (by Technology type) in Tissue  Imaging Market
Figure 11.8: Global Tissue Imaging Market (by Academic and Research Institutions), 2019-2030
Figure 11.9: Academic and Research Institutions, (by Technology Type) in Tissue Imaging Market
Figure 11.10: Global Tissue Imaging Market (by Hospitals and Diagnostic Laboratories), 2019-2030
Figure 11.11: Hospitals and Diagnostic Laboratories, (by Technology Type) in Tissue Imaging Market
Figure 12.1: Shares of Key Company Profiles
Figure 12.2: Abbott Laboratories: Product Portfolio for Global Tissue Imaging Market In-Situ Hybridization
Figure 12.3: Abbott Laboratories: Overall Financials, 2017-2019
Figure 12.4: Abbott Laboratories: Revenue (by Business Segment), 2017-2019
Figure 12.5: Abbott Laboratories: Revenue (by Region), 2017-2019
Figure 12.6: Abbott Laboratories: R&D Expenditure (2017-2019)
Figure 12.7: Abbott Laboratories: SWOT Analysis
Figure 12.8: Abcam Plc: Product Portfolio for Global Tissue Imaging Market, Immunohistochemistry
Figure 12.9: Abcam Plc: Product Portfolio for Global Tissue Imaging Market, Immunofluorescence
Figure 12.10: Abcam Plc: Overall Financials, 2017-2019
Figure 12.11: Abcam Plc: Revenue (by Business Segment), 2017-2019
Figure 12.12: Abcam Plc: (by Region), 2017-2019
Figure 12.13: Abcam Plc: R&D Expenditure (2017-2019)
Figure 12.14: Abcam Plc.: SWOT Analysis
Figure 12.15: Agilent Technologies, Inc.: Product Portfolio for Global Tissue Imaging Testing Market, Immunohistochemistry
Figure 12.16: Agilent Technologies, Inc.: Product Portfolio for Global Tissue Imaging Testing Market, In situ Hybridization
Figure 12.17: Agilent Technologies, Inc.: Product Portfolio for Global Tissue Imaging Testing Market, Flow Cytometry
Figure 12.18: Agilent Technologies, Inc.: Product Portfolio for Global Tissue Imaging Testing Market, Mass Spectroscopy Imaging
Figure 12.19: Agilent Technologies, Inc.: Overall Financials, 2017-2019
Figure 12.20: Agilent Technologies, Inc.: Revenue (by Business Segment), 2017-2019
Figure 12.21: Agilent Technologies, Inc.: (by Region), 2017-2019
Figure 12.22: Agilent Technologies, Inc.: R&D Expenditure (2017-2019)
Figure 12.23: Agilent Technologies, Inc.: SWOT Analysis
Figure 12.24: Bio-Rad Laboratories, Inc.: Product Portfolio for Global Tissue Imaging Testing Market, Flow Cytometry
Figure 12.25: Bio-Rad Laboratories, Inc.: Product Portfolio for Global Tissue Imaging Testing Market, Immunohistochemistry
Figure 12.26: Bio-Rad Laboratories, Inc.: Product Portfolio for Global Tissue Imaging Testing Market, Immunofluorescence
Figure 12.27: Bio-Rad Laboratories, Inc.: Product Portfolio for Global Tissue Imaging Testing Market, Mass Spectroscopy Imaging
Figure 12.28: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
Figure 12.29: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.30: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 12.31: Bio-Rad Laboratories, Inc.: R&D Expenditure (2016-2018)
Figure 12.32: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 12.33: Bio SB: Product Offerings for the Global Tissue Imaging Market
Figure 12.34: Bio SB: SWOT Analysis
Figure 12.35: Biocare Medical: Product Offerings for the Global Tissue Imaging Market
Figure 12.36: Biocare Medical: SWOT Analysis
Figure 12.37: Beckton, Dickinson and Company: Existing Product Offerings in the Global Tissue Imaging Market, Flow Cytometry
Figure 12.38: Becton, Dickinson and Company: Overall Financials, 2017-2019
Figure 12.39: Becton, Dickinson and Company: Revenue (by Business Segment), 2017-2019
Figure 12.40: Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2017-2019
Figure 12.41: Becton, Dickinson and Company: Revenue (by Region), 2017-2019
Figure 12.42: Becton, Dickinson and Company: R&D Expenditure, 2017-2019
Figure 12.43: Becton, Dickinson and Company: SWOT Analysis
Figure 12.44: Danaher Corporation: Product Portfolio for Global Tissue Imaging Market, Beckman Coulter, Inc.- Flow Cytometry
Figure 12.45: Danaher Corporation: Product Portfolio for Global Tissue Imaging Market, Leica Biosystems Nussloch GmbH: Digital Pathology
Figure 12.46: Danaher Corporation: Product Portfolio for Global Tissue Imaging Market, Leica Biosystems Nussloch GmbH: In-Situ Hybridization
Figure 12.47: Danaher Corporation: Product Portfolio for Global Tissue Imaging Market, AB Sciex Pte Ltd: Mass Spectroscopy Imaging
Figure 12.48: Danaher Corporation: Overall Financials, 2016-2018
Figure 12.49: Danaher Corporation: Revenue (by Business Segment), 2016-2018
Figure 12.50: Danaher Corporation: Revenue (by Region), 2016-2018
Figure 12.51: Danaher Corporation: R&D Expenditure (2016-2018)
Figure 12.52: Danaher Corporation: SWOT Analysis
Figure 12.53: Fluidigm Corporation: Product Portfolio for the Global Tissue Imaging Market, Mass Spectroscopy Imaging
Figure 12.54: Fluidigm Corporation: Overall Financials, 2017-2019
Figure 12.55: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
Figure 12.56: Fluidigm Corporation.: (by Region), 2017-2019
Figure 12.57: Fluidigm Corporation: R&D Expenditure (2017-2019)
Figure 12.58: Fluidigm Corporation: SWOT Analysis
Figure 12.59: F. Hoffmann-La Roche Ltd: Product Portfolio for the Global Tissue Imaging Market, Digital Pathology
Figure 12.60: F. Hoffmann-La Roche Ltd: Product Portfolio for the Global Tissue Imaging Market, Immunohistochemistry
Figure 12.61: F. Hoffmann-La Roche Ltd: Overall Financials, 2017-2019
Figure 12.62: F. Hoffmann-La Roche Ltd: Revenue (by Business Segment), 2017-2019
Figure 12.63: F. Hoffmann-La Roche Ltd: (Revenue by Diagnostics Segment), 2017-2019
Figure 12.64: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2016-2018
Figure 12.65: F. Hoffmann-La Roche Ltd: R&D Expenditure (2017-2019)
Figure 12.66: F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 12.67: Hamamatsu Photonics K.K. : Product Offerings for Global Tissue Imaging Market, Mass Spectroscopy Imaging
Figure 12.68: Overall Financials, 2017-2019
Figure 12.69: Hamamatsu Photonics K.K.: Net Revenue (by Business Segment),  2017-2019
Figure 12.70: Hamamatsu Photonics K.K. : R&D Expense, 2017-2019
Figure 12.71: Hamamatsu Photonics K.K.: SWOT Analysis
Figure 12.72: Nikon Corporation: Product Portfolio for the Global Tissue Imaging Market, Digital Pathology
Figure 12.73: Nikon Corporation: Overall Financials, 2017-2019
Figure 12.74: Nikon Corporation: Revenue (by Business Segment), 2017-2019
Figure 12.75: Nikon Corporation: (by Region), 2017-2019
Figure 12.76: Nikon Corporation: R&D Expenditure (2017-2019)
Figure 12.77: Nikon Corporation: SWOT Analysis
Figure 12.78: PerkinElmer Inc.: Product Portfolio for Global Tissue Imaging Market, Digital Pathology
Figure 12.79: PerkinElmer Inc.: Product Portfolio for Global Tissue Imaging Market, Mass Spectroscopy Imaging
Figure 12.80: PerkinElmer Inc.: Product Portfolio for Global Tissue Imaging Market, In Situ Hybridization
Figure 12.81: PerkinElmer Inc.: Overall Financials, 2017-2019
Figure 12.82: PerkinElmer Inc.: Revenue (by Business Segment), 2017-2019
Figure 12.83: PerkinElmer Inc.: (by Region), 2017-2019
Figure 12.84: PerkinElmer Inc.: R&D Expenditure (2017-2019)
Figure 12.85: Perkinelmer, Inc.: SWOT Analysis
Figure 12.86: Sakura Finetek: Product Offerings for the Global Tissue Imaging Market, Digital Pathology
Figure 12.87: Sakura Finetek: Product Offerings for the Global Tissue Imaging Market, Immunohistochemistry
Figure 12.88: Sakura Finetek: SWOT Analysis
Figure 12.89: LifeSpan BioSciences, Inc.: Product Offerings for the Global Tissue Imaging Market, Immunohistochemistry
Figure 12.90: LifeSpan BioSciences, Inc.: SWOT Analysis
Figure 12.91: Merck KGaA: Product Portfolio for the Global Tissue Imaging Market, Immunohistochemistry
Figure 12.92: Merck KGaA: Product Portfolio for the Global Tissue Imaging Market, Immunofluorescence
Figure 12.93: Merck KGaA: Overall Financials, 2017-2019
Figure 12.94: Merck KGaA.: Revenue (by Business Segment), 2017-2019
Figure 12.95: Merck KGaA.: Revenue (by Region), 2017-2019
Figure 12.96: Merck KGaA: R&D Expenditure (2017-2019)
Figure 12.97: Merck KGaA.: SWOT Analysis
Figure 12.98: Olympus Corporation: Product Portfolio for Global Tissue Imaging Market, Digital Pathology
Figure 12.99: Olympus Corporation: Overall Financials, 2016-2018
Figure 12.100: Olympus Corporation: Revenue (by Business Segment), 2016-2018
Figure 12.101: Olympus Corporation: (by Region), 2017-2019
Figure 12.102: Olympus Corporation.: R&D Expenditure (2017-2019)
Figure 12.103: Olympus Corporation.: SWOT Analysis
Figure 12.104: Thermo Fisher Scientific Inc.: Product Portfolio for Global Tissue Imaging Market, Flow Cytometer
Figure 12.105: Thermo Fisher Scientific Inc.: Product Portfolio for Global Tissue Imaging Market, Immunofluorescence
Figure 12.106: Thermo Fisher Scientific Inc.: Product Portfolio for Global Tissue Imaging Market, In-Situ Hybridization
Figure 12.107: Thermo Fisher Scientific Inc.: Product Portfolio for Global Tissue Imaging Market, Mass Spectroscopy Imaging
Figure 12.108: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 12.109: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2016-2018
Figure 12.110: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 12.111: Thermo Fisher Scientific Inc.: R&D Expenditure (2016-2018)
Figure 12.112: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 12.113: Product Offerings for the Global Tissue Imaging Market, Mass Spectroscopy Imaging
Figure 12.114: Overall Financials, 2016-2018
Figure 12.115: Net Revenue (by Business Segment), 2016-2018
Figure 12.116: Shimadzu Corporation: Net Revenue (by Region), 2016-2018
Figure 12.117: R&D Expense, 2016-2018
Figure 12.118: Shimadzu Corporation: SWOT Analysis
Figure 12.119: Vector Laboratories Offerings for the Global Tissue Imaging Market, Immunofluorescence
Figure 12.120: Vector Laboratories: SWOT Analysis
Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio SB
  • Danaher Corporation
  • Fluidigm Corporation
  • Merck KGaA
  • Olympus Corporation

According to the market intelligence report titled “Global Tissue Imaging Market – Analysis and Forecast: 2020-2030,” the global tissue imaging market is anticipated to witness a significant CAGR of 8.96% in the forecast period 2020-2030. Owing to the rising awareness about early diagnosis and detection of diseases coupled with increasing cases of chronic diseases, the market is expected to grow up to $37.44 billion by the end of 2030.

The rise in the incidence of chronic diseases such as cancer and cardiovascular diseases has directed inventions in the field of medicine and imaging in the last few decades. The tissue imaging practices have evolved over time and have become advanced, providing faster and accurate results. Also, currently, drug companies are pro-actively employing tissue imaging techniques and human tissue samples in all stages of drug discovery and development. Tissue imaging has been witnessing impressive growth in demand across the globe because of a rise in the incidence rate of cancer. According to the Global Health Data Exchange, the incidence rate of cancer increased from 301.91 in 2014 to 318.85 per 100,000 people in 2017. Likewise, the incidence of cardiovascular diseases has also increased at substantial rates since the past decades. According to the Global Health Data Exchange, the incidence rate of cardiovascular disorders increased from 885.93 in 2014 to 951.79 per 100,000 people in 2017. Moreover, as of 2019, in the U.S., the prevalence of neurological disorders was registered to be 158.2 million, and the same year, the U.S. witnessed an incidence of 50.2 million cases. Similarly, according to Institute for Health Metrics and Evaluation, the global prevalence of neurological disorders such as Alzheimer's disease, Epilepsy, Multiple sclerosis, and Parkinson’s disease, among others, was registered to be 3.12 billion in 2017, and the same year witnessed 3.09 million deaths and incidence of 1.00 billion neurological cases The rise in the incidence of chronic diseases is leading to increased efforts to enhance the quality of life by investing in drug discovery and diagnostics research.

Tissue Imaging forms an important part of cancer clinical protocols and can furnish morphological, metabolic, structural, and functional information. It is utilized to screen, diagnose, and stage cancer, monitor cancer treatments, establish the effectiveness of cancer therapy and monitor cancer recurrence. Integration of oncology medical imaging with other clinical tools, such as biomarker tests, in vitro tissue analysis, and cancer screening, enhance decision making. Quick detection through screening based on imaging is the major contributor to a decrease in the number of deaths caused by specific types of cancer. The use of immunohistochemistry to molecular genomics, image analyzer and AI, proteomics, cell-free DNA, advances in next-generation sequencing, are few of the technological advancements that seem promising. Moreover, the use of digital pathology aids clinicians in the identification of new histological areas. Digital pathology contributes to standardizing phenotypic features linked to malignant phenotypes and thus helps in faster and accurate screening and analysis of the cancer cases. The growth in personalized medicine segment is further poised to increase the demand for tissue diagnostics in the field of oncology, cardiology, neurology, immunology, and infectious diseases to name a few.

“Oncology segment is the fastest-growing segment of the tissue imaging market during the forecast period 2020-2030. The application type is anticipated to grow at an impressive CAGR of 8.66% during the forecast period 2020-2030.”

Research Highlights:

•    The leading contributors to the global tissue imaging market predominantly prefer synergistic activities such as partnerships, and collaborations to strengthen their operations across the globe, and to enhance their respective dominance. Moreover, many of the market leaders are collaborating with technology-based startups or with emerging players to gain expertise in technology.
•    The market for global tissue imaging market specific to technology type (Digital Pathology) is anticipated to witness a notable CAGR of 10.80% during the forecast period.

This market intelligence report provides a multidimensional view of the global tissue imaging market in terms of market size and growth potential. This research report aims at answering various aspects of the tissue imaging market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of market expansion.

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities such as business portfolio expansions, partnerships, and acquisitions. The research report provides a comprehensive analysis of the service sales, and manufacturers and trend analysis by segments such as application, technology, product, end users, and by region.

This report is a meticulous compilation of research on more than 15 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of the leading companies, market participants, and vendors. The report also profiles 15 companies including several key players, i.e. Abbott Laboratories, Agilent Technologies, Abcam Plc, Bio-Rad Laboratories, Inc., Danaher Corporation, Fluidigm Corporation, Olympus Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Hamamatsu Photonics K.K., Becton, Dickinson and Company, Nikon Corporation, PerkinElmer Inc., Shimadzu Corporation, and Thermo Fisher Scientific Inc., among others.































Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Abcam Plc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio SB
  • Biocare Medical
  • Becton, Dickinson, and Company
  • Danaher Corporation
  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd
  • Hamamatsu Photonics K.K.
  • Nikon Corporation
  • PerkinElmer Inc.
  • Sakura Finetek
  • LifeSpan BioSciences, Inc.
  • Merck KGaA
  • Olympus Corporation
  • Thermo Fisher Scientific Inc.
  • Shimadzu Corporation
  • Vector Laboratories
Note: Product cover images may vary from those shown

Loading
LOADING...